Genomma Lab InternacionalB de CV (MEX:LABB) Cash Flow for Lease Financing: MXN-64 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:LABB Genomma Lab Internacional SAB de CV MEX:LABB
59 GF Score
Price MXN14.22
GF Value MXN17.13
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Genomma Lab InternacionalB de CV Cash Flow for Lease Financing?

Genomma Lab InternacionalB de CV MEX:LABB -1.04% 59 Cash Flow for Lease Financing is MXN-64 Mil as of Jun. 2026. GuruFocus rates MEX:LABB with a GF Score™ of 59/100 and a GF Value™ of MXN17.13 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Genomma Lab InternacionalB de CV's Cash Flow for Lease Financing for the three months ended in Jun. 2026 was MXN-14 Mil. Genomma Lab InternacionalB de CV's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jun. 2026 was MXN-64 Mil.

Compared with last quarter (MXN-13 Mil in Mar. 2026 ), Genomma Lab InternacionalB de CV's Cash Flow for Lease Financing remained the same in Jun. 2026 (MXN-14 Mil).

Genomma Lab InternacionalB de CV Cash Flow for Lease Financing Related Terms

Genomma Lab InternacionalB de CV Cash Flow for Lease Financing Historical Data

* Premium members only.

The historical data trend for Genomma Lab InternacionalB de CV's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genomma Lab InternacionalB de CV Cash Flow for Lease Financing Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -57.46 -42.86 -33.21 -89.73 -64.33

Genomma Lab InternacionalB de CV Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.60 -14.20 -22.30 -12.97 -14.26
MEX:LABB
59GF Score
Genomma Lab Internacional SAB de CV MEX:LABB
Cash Flow for Lease Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genomma Lab InternacionalB de CV Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Lease Financing of MXN-64 Mil mean?
Genomma Lab InternacionalB de CV (MEX:LABB) has a Cash Flow for Lease Financing of MXN-64 Mil as of Jun. 2026. Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing. View historical data on Genomma Lab InternacionalB de CV and its competitors.
Is Genomma Lab InternacionalB de CV's Cash Flow for Lease Financing too high?
Genomma Lab InternacionalB de CV's current Cash Flow for Lease Financing is MXN-64 Mil. Overall, Genomma Lab InternacionalB de CV has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genomma Lab InternacionalB de CV's Cash Flow for Lease Financing compare to ZTS and UTHR?
Genomma Lab InternacionalB de CV's Cash Flow for Lease Financing of MXN-64 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Lease Financing for a Drug Manufacturers company?
A good Cash Flow for Lease Financing depends on the Drug Manufacturers industry context. However, Cash Flow for Lease Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Lease Financing mean?
A high Cash Flow for Lease Financing can signal that a stock is expensive relative to its fundamentals. Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing. View historical data on Genomma Lab InternacionalB de CV and its competitors. Genomma Lab InternacionalB de CV's current Cash Flow for Lease Financing is MXN-64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomma Lab InternacionalB de CV stock overvalued right now?
Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV (MEX:LABB) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN17.13, compared to a current price of MXN14.22 — trading 17% below its estimated fair value. The current Cash Flow for Lease Financing is MXN-64 Mil. Genomma Lab InternacionalB de CV's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Lease Financing calculated?
Cash Flow for Lease Financing is calculated from a company's financial statements. For Genomma Lab InternacionalB de CV (MEX:LABB), the current Cash Flow for Lease Financing is MXN-64 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genomma Lab InternacionalB de CV (MEX:LABB) Overvalued in 2026?

Based on GuruFocus' analysis, Genomma Lab InternacionalB de CV stock appears to be undervalued. The current stock price of MXN14.22 is trading 17% below its estimated GF Value™ of MXN17.13. GuruFocus considers Genomma Lab InternacionalB de CV to be Modestly Undervalued.

Key valuation signals for MEX:LABB:

  • Cash Flow for Lease Financing: MXN-64 Mil
  • GF Value™: MXN17.13 vs. price of MXN14.22 (17% below fair value)
  • GF Score™: 59/100 with 3 warning signs

No single metric tells the full story. See the MEX:LABB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genomma Lab InternacionalB de CV Business Description

Other Exchanges GNMLF:USAGEKA:Germany
Address Avenida Antonio Dovali Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
59GF Score

Get the complete analysis for MEX:LABB

Cash Flow for Lease Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN14.22
Price
MXN17.13
GF Value